Back
State Bank of India Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
73
SBKFF
State Bank of India
Last Price:
$85.00
Seasonality Move:
5.07%
Sell
48
ASND
Ascendis Pharma AS
Last Price:
$166.13
Seasonality Move:
-9.72%
Buy
73
State Bank of India (SBKFF)
is a Buy
Is State Bank of India a Buy, Sell or Hold?
-
The current State Bank of India [SBKFF] share price is $89.50. The Score for SBKFF is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
SBKFF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $164.65. The Score for ASND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SBKFF Stock Price Chart
What is State Bank of India's stock price today?
-
The State Bank of India share price today is $89.50The current trend is relatively stagnant and SBKFF is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $164.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
SBKFF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.27 | Buy |
Relative Strength Index (14 RSI): | 86.16 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (79.37 - 85.09) | Buy |
Bollinger Bands (100): | (82.64 - 98.48) | Sell |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.96 | Buy |
Relative Strength Index (14 RSI): | 63.68 | Buy |
Chaikin Money Flow: | -280747 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.08 - 160.62) | Buy |
Bollinger Bands (100): | (124.26 - 145.68) | Buy |
SBKFF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.37 | Buy |
20-day SMA: | 82.6 | Buy |
50-day SMA: | 83.4 | Buy |
200-day SMA: | 95.16 | Sell |
8-day EMA: | 86.17 | Buy |
20-day EMA: | 83.9 | Buy |
50-day EMA: | 85.09 | Buy |
200-day EMA: | 89.49 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 154.01 | Buy |
20-day SMA: | 153.39 | Buy |
50-day SMA: | 139.38 | Buy |
200-day SMA: | 134.63 | Buy |
8-day EMA: | 157.06 | Buy |
20-day EMA: | 151.09 | Buy |
50-day EMA: | 143.18 | Buy |
200-day EMA: | 134.95 | Buy |
State Bank of India Earnings Growth & SBKFF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.82 per share, an increase next quarter of $0.04 per share, an increase this year of $3.21 per share, and an increase next year of $5.31 per share.
State Bank of India Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |